Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-218809
Filing Date
2012-05-08
Accepted
2012-05-08 17:03:05
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d342330d10q.htm 10-Q 621807
2 SETTLEMENT AND LICENSE AGREEMENT, DATED FEBRUARY 22, 2012 d342330dex101.htm EX-10.1 117167
3 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d342330dex311.htm EX-31.1 7408
4 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER d342330dex312.htm EX-31.2 7618
5 CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER SECTION 1350 CERTIFICATIONS d342330dex32.htm EX-32 7482
  Complete submission text file 0001193125-12-218809.txt   2158476

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snts-20120331.xml EX-101.INS 216915
7 XBRL TAXONOMY EXTENSION SCHEMA snts-20120331.xsd EX-101.SCH 12951
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snts-20120331_cal.xml EX-101.CAL 30729
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snts-20120331_lab.xml EX-101.LAB 113976
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snts-20120331_pre.xml EX-101.PRE 66053
Mailing Address 3721 VALLEY CENTRE DRIVE STE 400 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DRIVE STE 400 SAN DIEGO CA 92130 8583145700
SANTARUS INC (Filer) CIK: 0001172480 (see all company filings)

EIN.: 330734433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50651 | Film No.: 12822274
SIC: 2834 Pharmaceutical Preparations